1232030-77-1

Basic information

• Product Name: methyl (4R)‐4‐[(1R,3aS,3bR,4S,5aS,7R,9aS,9bS,11aR)‐7‐hydroxy‐9a,11a‐dimethyl‐4‐[(4‐methylbenzenesulfonyl)oxy]‐hexadecahydro‐1H‐cyclopenta[a]phenanthren‐1‐yl]pentanoate
• Synonyms: methyl (4R)‐4‐[(1R,3aS,3bR,4S,5aS,7R,9aS,9bS,11aR)‐7‐hydroxy‐9a,11a‐dimethyl‐4‐[(4‐methylbenzenesulfonyl)oxy]‐hexadecahydro‐1H‐cyclopenta[a]phenanthren‐1‐yl]pentanoate
• CAS NO: 1232030-77-1
• Molecular Weight: 560.796
• Mol File: 1232030-77-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl (4R)‐4‐[(1R,3aS,3bR,4S,5aS,7R,9aS,9bS,11aR)‐7‐hydroxy‐9a,11a‐dimethyl‐4‐[(4‐methylbenzenesulfonyl)oxy]‐hexadecahydro‐1H‐cyclopenta[a]phenanthren‐1‐yl]pentanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (4R)‐4‐[(1R,3aS,3bR,4S,5aS,7R,9aS,9bS,11aR)‐7‐hydroxy‐9a,11a‐dimethyl‐4‐[(4‐methylbenzenesulfonyl)oxy]‐hexadecahydro‐1H‐cyclopenta[a]phenanthren‐1‐yl]pentanoate(1232030-77-1)
• EPA Substance Registry System: methyl (4R)‐4‐[(1R,3aS,3bR,4S,5aS,7R,9aS,9bS,11aR)‐7‐hydroxy‐9a,11a‐dimethyl‐4‐[(4‐methylbenzenesulfonyl)oxy]‐hexadecahydro‐1H‐cyclopenta[a]phenanthren‐1‐yl]pentanoate(1232030-77-1)

Safety Data

• Hazardous Substances Data: 1232030-77-1(Hazardous Substances Data)

Upstream product

• 128-13-2 ursodeoxycholic acid 
• 10538-55-3 3α,7β-dihydroxy-5β-cholan-24-oic acid methyl ester 
• 98-59-9 p-toluenesulfonyl chloride 

Relevant articles and documents

SYNTHETIC DERIVATIVES OF CHOLIC ACID 7-SULFATE AND USES THEREOF

The compositions and methods provided herein are related, in part, to the discovery of cholic acid 7-sulfate as a treatment for diabetes. Provided herein is a method for treating a metabolic disorder (e.g., diabetes, obesity), or an inflammatory disease (e.g., Crohn's disease, inflammatory bowel disease, ulcerative colitis, pancreatitis, hepatitis, appendicitis, gastritis, diverticulitis, celiac disease, food intolerance, enteritis, ulcer, gastroesophageal reflux disease (GERD), psoriatic arthritis, psoriasis, and rheumatoid arthritis) in a subject in need thereof comprising administering to a subject a compound of Formulae (I)-(XVII).